The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Osteoarthritis Medications Market Research Report 2025
Synopsis
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
The global Osteoarthritis Medications market was valued at US$ 9238 million in 2023 and is anticipated to reach US$ 11720 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Medications.
Report Scope
The Osteoarthritis Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoarthritis Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Osteoarthritis Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics
Segment by Type
NSAIDs
Corticosteroids
Hyaluronic Acid Injection
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Osteoarthritis Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
The global Osteoarthritis Medications market was valued at US$ 9238 million in 2023 and is anticipated to reach US$ 11720 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Medications.
Report Scope
The Osteoarthritis Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoarthritis Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Osteoarthritis Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics
Segment by Type
NSAIDs
Corticosteroids
Hyaluronic Acid Injection
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Osteoarthritis Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoarthritis Medications Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Hyaluronic Acid Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Osteoarthritis Medications Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Osteoarthritis Medications Market Perspective (2019-2030)
2.2 Osteoarthritis Medications Growth Trends by Region
2.2.1 Global Osteoarthritis Medications Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Osteoarthritis Medications Historic Market Size by Region (2019-2024)
2.2.3 Osteoarthritis Medications Forecasted Market Size by Region (2025-2030)
2.3 Osteoarthritis Medications Market Dynamics
2.3.1 Osteoarthritis Medications Industry Trends
2.3.2 Osteoarthritis Medications Market Drivers
2.3.3 Osteoarthritis Medications Market Challenges
2.3.4 Osteoarthritis Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteoarthritis Medications Players by Revenue
3.1.1 Global Top Osteoarthritis Medications Players by Revenue (2019-2024)
3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2019-2024)
3.2 Global Osteoarthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Osteoarthritis Medications Revenue
3.4 Global Osteoarthritis Medications Market Concentration Ratio
3.4.1 Global Osteoarthritis Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Medications Revenue in 2023
3.5 Osteoarthritis Medications Key Players Head office and Area Served
3.6 Key Players Osteoarthritis Medications Product Solution and Service
3.7 Date of Enter into Osteoarthritis Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteoarthritis Medications Breakdown Data by Type
4.1 Global Osteoarthritis Medications Historic Market Size by Type (2019-2024)
4.2 Global Osteoarthritis Medications Forecasted Market Size by Type (2025-2030)
5 Osteoarthritis Medications Breakdown Data by Application
5.1 Global Osteoarthritis Medications Historic Market Size by Application (2019-2024)
5.2 Global Osteoarthritis Medications Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Osteoarthritis Medications Market Size (2019-2030)
6.2 North America Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Osteoarthritis Medications Market Size by Country (2019-2024)
6.4 North America Osteoarthritis Medications Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Osteoarthritis Medications Market Size (2019-2030)
7.2 Europe Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Osteoarthritis Medications Market Size by Country (2019-2024)
7.4 Europe Osteoarthritis Medications Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Osteoarthritis Medications Market Size (2019-2030)
8.2 Asia-Pacific Osteoarthritis Medications Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Osteoarthritis Medications Market Size by Region (2019-2024)
8.4 Asia-Pacific Osteoarthritis Medications Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Osteoarthritis Medications Market Size (2019-2030)
9.2 Latin America Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Osteoarthritis Medications Market Size by Country (2019-2024)
9.4 Latin America Osteoarthritis Medications Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteoarthritis Medications Market Size (2019-2030)
10.2 Middle East & Africa Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Osteoarthritis Medications Market Size by Country (2019-2024)
10.4 Middle East & Africa Osteoarthritis Medications Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Osteoarthritis Medications Introduction
11.1.4 Pfizer Revenue in Osteoarthritis Medications Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Osteoarthritis Medications Introduction
11.2.4 Johnson & Johnson Revenue in Osteoarthritis Medications Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Osteoarthritis Medications Introduction
11.3.4 GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Osteoarthritis Medications Introduction
11.4.4 Novartis Revenue in Osteoarthritis Medications Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Osteoarthritis Medications Introduction
11.5.4 Bayer Revenue in Osteoarthritis Medications Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Osteoarthritis Medications Introduction
11.6.4 Eli Lilly Revenue in Osteoarthritis Medications Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Osteoarthritis Medications Introduction
11.7.4 Sanofi Revenue in Osteoarthritis Medications Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Detail
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Osteoarthritis Medications Introduction
11.8.4 Horizon Pharma Revenue in Osteoarthritis Medications Business (2019-2024)
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Osteoarthritis Medications Introduction
11.9.4 Abbott Revenue in Osteoarthritis Medications Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Osteoarthritis Medications Introduction
11.10.4 Mylan Revenue in Osteoarthritis Medications Business (2019-2024)
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Detail
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Osteoarthritis Medications Introduction
11.11.4 Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2019-2024)
11.11.5 Daiichi Sankyo Recent Development
11.12 TEVA
11.12.1 TEVA Company Detail
11.12.2 TEVA Business Overview
11.12.3 TEVA Osteoarthritis Medications Introduction
11.12.4 TEVA Revenue in Osteoarthritis Medications Business (2019-2024)
11.12.5 TEVA Recent Development
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Detail
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Osteoarthritis Medications Introduction
11.13.4 Almatica Pharma Revenue in Osteoarthritis Medications Business (2019-2024)
11.13.5 Almatica Pharma Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Detail
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Osteoarthritis Medications Introduction
11.14.4 Astellas Pharma Revenue in Osteoarthritis Medications Business (2019-2024)
11.14.5 Astellas Pharma Recent Development
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Detail
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Osteoarthritis Medications Introduction
11.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024)
11.15.5 Tide Pharmaceutical Recent Development
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Detail
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2019-2024)
11.16.5 Iroko Pharmaceuticals Recent Development
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Detail
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024)
11.17.5 Hengrui Pharmaceutical Recent Development
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Detail
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Osteoarthritis Medications Introduction
11.18.4 Abiogen Pharma Revenue in Osteoarthritis Medications Business (2019-2024)
11.18.5 Abiogen Pharma Recent Development
11.19 Flexion Therapeutics
11.19.1 Flexion Therapeutics Company Detail
11.19.2 Flexion Therapeutics Business Overview
11.19.3 Flexion Therapeutics Osteoarthritis Medications Introduction
11.19.4 Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024)
11.19.5 Flexion Therapeutics Recent Development
11.20 Anika Therapeutics
11.20.1 Anika Therapeutics Company Detail
11.20.2 Anika Therapeutics Business Overview
11.20.3 Anika Therapeutics Osteoarthritis Medications Introduction
11.20.4 Anika Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024)
11.20.5 Anika Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Osteoarthritis Medications Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of NSAIDs
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Hyaluronic Acid Injection
Table 5. Key Players of Others
Table 6. Global Osteoarthritis Medications Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Osteoarthritis Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Osteoarthritis Medications Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Osteoarthritis Medications Market Share by Region (2019-2024)
Table 10. Global Osteoarthritis Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Osteoarthritis Medications Market Share by Region (2025-2030)
Table 12. Osteoarthritis Medications Market Trends
Table 13. Osteoarthritis Medications Market Drivers
Table 14. Osteoarthritis Medications Market Challenges
Table 15. Osteoarthritis Medications Market Restraints
Table 16. Global Osteoarthritis Medications Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Osteoarthritis Medications Market Share by Players (2019-2024)
Table 18. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2023)
Table 19. Ranking of Global Top Osteoarthritis Medications Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Osteoarthritis Medications Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Osteoarthritis Medications Product Solution and Service
Table 23. Date of Enter into Osteoarthritis Medications Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Osteoarthritis Medications Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Osteoarthritis Medications Revenue Market Share by Type (2019-2024)
Table 27. Global Osteoarthritis Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Osteoarthritis Medications Revenue Market Share by Type (2025-2030)
Table 29. Global Osteoarthritis Medications Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Osteoarthritis Medications Revenue Market Share by Application (2019-2024)
Table 31. Global Osteoarthritis Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Osteoarthritis Medications Revenue Market Share by Application (2025-2030)
Table 33. North America Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Osteoarthritis Medications Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Osteoarthritis Medications Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Osteoarthritis Medications Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Osteoarthritis Medications Product
Table 51. Pfizer Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Osteoarthritis Medications Product
Table 56. Johnson & Johnson Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. GlaxoSmithKline Company Detail
Table 59. GlaxoSmithKline Business Overview
Table 60. GlaxoSmithKline Osteoarthritis Medications Product
Table 61. GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 62. GlaxoSmithKline Recent Development
Table 63. Novartis Company Detail
Table 64. Novartis Business Overview
Table 65. Novartis Osteoarthritis Medications Product
Table 66. Novartis Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Bayer Company Detail
Table 69. Bayer Business Overview
Table 70. Bayer Osteoarthritis Medications Product
Table 71. Bayer Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Eli Lilly Company Detail
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Osteoarthritis Medications Product
Table 76. Eli Lilly Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. Sanofi Company Detail
Table 79. Sanofi Business Overview
Table 80. Sanofi Osteoarthritis Medications Product
Table 81. Sanofi Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Horizon Pharma Company Detail
Table 84. Horizon Pharma Business Overview
Table 85. Horizon Pharma Osteoarthritis Medications Product
Table 86. Horizon Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 87. Horizon Pharma Recent Development
Table 88. Abbott Company Detail
Table 89. Abbott Business Overview
Table 90. Abbott Osteoarthritis Medications Product
Table 91. Abbott Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Mylan Company Detail
Table 94. Mylan Business Overview
Table 95. Mylan Osteoarthritis Medications Product
Table 96. Mylan Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 97. Mylan Recent Development
Table 98. Daiichi Sankyo Company Detail
Table 99. Daiichi Sankyo Business Overview
Table 100. Daiichi Sankyo Osteoarthritis Medications Product
Table 101. Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 102. Daiichi Sankyo Recent Development
Table 103. TEVA Company Detail
Table 104. TEVA Business Overview
Table 105. TEVA Osteoarthritis Medications Product
Table 106. TEVA Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 107. TEVA Recent Development
Table 108. Almatica Pharma Company Detail
Table 109. Almatica Pharma Business Overview
Table 110. Almatica Pharma Osteoarthritis Medications Product
Table 111. Almatica Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 112. Almatica Pharma Recent Development
Table 113. Astellas Pharma Company Detail
Table 114. Astellas Pharma Business Overview
Table 115. Astellas Pharma Osteoarthritis Medications Product
Table 116. Astellas Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 117. Astellas Pharma Recent Development
Table 118. Tide Pharmaceutical Company Detail
Table 119. Tide Pharmaceutical Business Overview
Table 120. Tide Pharmaceutical Osteoarthritis Medications Product
Table 121. Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 122. Tide Pharmaceutical Recent Development
Table 123. Iroko Pharmaceuticals Company Detail
Table 124. Iroko Pharmaceuticals Business Overview
Table 125. Iroko Pharmaceuticals Osteoarthritis Medications Product
Table 126. Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 127. Iroko Pharmaceuticals Recent Development
Table 128. Hengrui Pharmaceutical Company Detail
Table 129. Hengrui Pharmaceutical Business Overview
Table 130. Hengrui Pharmaceutical Osteoarthritis Medications Product
Table 131. Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 132. Hengrui Pharmaceutical Recent Development
Table 133. Abiogen Pharma Company Detail
Table 134. Abiogen Pharma Business Overview
Table 135. Abiogen Pharma Osteoarthritis Medications Product
Table 136. Abiogen Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 137. Abiogen Pharma Recent Development
Table 138. Flexion Therapeutics Company Detail
Table 139. Flexion Therapeutics Business Overview
Table 140. Flexion Therapeutics Osteoarthritis Medications Product
Table 141. Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 142. Flexion Therapeutics Recent Development
Table 143. Anika Therapeutics Company Detail
Table 144. Anika Therapeutics Business Overview
Table 145. Anika Therapeutics Osteoarthritis Medications Product
Table 146. Anika Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)
Table 147. Anika Therapeutics Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteoarthritis Medications Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Osteoarthritis Medications Market Share by Type: 2023 VS 2030
Figure 3. NSAIDs Features
Figure 4. Corticosteroids Features
Figure 5. Hyaluronic Acid Injection Features
Figure 6. Others Features
Figure 7. Global Osteoarthritis Medications Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Osteoarthritis Medications Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Osteoarthritis Medications Report Years Considered
Figure 13. Global Osteoarthritis Medications Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Osteoarthritis Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Osteoarthritis Medications Market Share by Region: 2023 VS 2030
Figure 16. Global Osteoarthritis Medications Market Share by Players in 2023
Figure 17. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Osteoarthritis Medications Revenue in 2023
Figure 19. North America Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Osteoarthritis Medications Market Share by Country (2019-2030)
Figure 21. United States Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Osteoarthritis Medications Market Share by Country (2019-2030)
Figure 25. Germany Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Osteoarthritis Medications Market Share by Region (2019-2030)
Figure 33. China Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Osteoarthritis Medications Market Share by Country (2019-2030)
Figure 41. Mexico Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Osteoarthritis Medications Market Share by Country (2019-2030)
Figure 45. Turkey Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 52. Eli Lilly Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 54. Horizon Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 55. Abbott Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 56. Mylan Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 57. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 58. TEVA Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 59. Almatica Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 60. Astellas Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 61. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 62. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 63. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 64. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 65. Flexion Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 66. Anika Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
